loadpatents
name:-0.025250911712646
name:-0.020940065383911
name:-0.0025219917297363
Morriello; Gregori J. Patent Filings

Morriello; Gregori J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morriello; Gregori J..The latest application filed is for "1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".

Company Profile
2.26.29
  • Morriello; Gregori J. - Randolph NJ
  • Morriello; Gregori J. - Rahway NJ US
  • Morriello; Gregori J. - Westfield NJ
  • Morriello; Gregori J. - Belleville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1-pyrazolyl, 5-, 6- Disubstituted Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20220259188 - Zhou; Hua ;   et al.
2022-08-18
N-heteroaryl Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20210395236 - SIMOV; Vladimir ;   et al.
2021-12-23
Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
Grant 10,647,727 - Morriello , et al.
2020-05-12
Substituted triazolo bicyclic compounds as PDE2 inhibitors
Grant 10,357,481 - Morriello , et al. July 23, 2
2019-07-23
Piperazine derivatives as HIV protease inhibitors
Grant 10,138,255 - Williams , et al. Nov
2018-11-27
Substituted Triazolo Bicyclic Compounds As Pde2 Inhibitors
App 20180169072 - MORRIELLO; Gregori J. ;   et al.
2018-06-21
Substituted Pyrazolo/imidazolo Bicyclic Compounds As Pde2 Inhibitors
App 20180162874 - Morriello; Gregori J. ;   et al.
2018-06-14
Piperazine derivatives as HIV protease inhibitors
Grant 9,840,478 - Williams , et al. December 12, 2
2017-12-12
Piperazine Derivatives As Hiv Protease Inhibitors
App 20170073354 - Williams; Peter D. ;   et al.
2017-03-16
Piperazine Derivatives As Hiv Protease Inhibitors
App 20160159752 - Williams; Peter D. ;   et al.
2016-06-09
Pyrrolidine derived .beta.3 adrenergic receptor agonists
Grant 9,186,354 - Morriello , et al. November 17, 2
2015-11-17
Substituted cyclopropyl compounds useful as GPR119 agonists
Grant 9,018,224 - Edmondson , et al. April 28, 2
2015-04-28
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
Grant 8,957,062 - Edmondson , et al. February 17, 2
2015-02-17
Pyrrolidine derived .beta.3 adrenergic receptor agonists
Grant 8,933,102 - Morriello , et al. January 13, 2
2015-01-13
Substituted Cyclopropyl Compounds Useful As Gpr119 Agonists
App 20140329798 - Edmondson; Scott ;   et al.
2014-11-06
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists
App 20140315912 - Morriello; Gregori J. ;   et al.
2014-10-23
Substituted Cycloproply Compounds, Compositions Containing Such Compounds And Methods Of Treatment
App 20140057893 - Edmondson; Scott ;   et al.
2014-02-27
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
Grant 8,653,260 - Berger , et al. February 18, 2
2014-02-18
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists
App 20130225599 - Morriello; Gregori J. ;   et al.
2013-08-29
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
Grant 8,501,786 - Berger , et al. August 6, 2
2013-08-06
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
Grant 8,399,480 - Berger , et al. March 19, 2
2013-03-19
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists
App 20120258963 - Berger; Richard ;   et al.
2012-10-11
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists
App 20120225886 - Edmondson; Scott D. ;   et al.
2012-09-06
Hydroxymethyl pyrrolidines as .beta.3 adrenergic receptor agonists
Grant 8,247,415 - Berger , et al. August 21, 2
2012-08-21
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists
App 20110028481 - Berger; Richard ;   et al.
2011-02-03
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists
App 20110028461 - Berger; Richard ;   et al.
2011-02-03
Anti-hypercholesterolemic compounds
Grant 7,704,988 - DeVita , et al. April 27, 2
2010-04-27
Heterocyclyl-substituted Anti-hypercholesterolemic Compounds
App 20100069347 - Morriello; Gregori J. ;   et al.
2010-03-18
Anti-hypercholesterolemic Compounds
App 20100035857 - DeVita; Robert J. ;   et al.
2010-02-11
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
App 20090286777 - Bao; Jianming ;   et al.
2009-11-19
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists
App 20090253705 - Berger; Richard ;   et al.
2009-10-08
Anti-Hypercholesterolemic Compounds
App 20090137546 - DeVita; Robert J. ;   et al.
2009-05-28
Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists
App 20090042854 - Bao; Jianming ;   et al.
2009-02-12
Anti-hypercholesterolemic biaryl azetidinone compounds
App 20080280836 - Morriello; Gregori J. ;   et al.
2008-11-13
Anti-hypercholesterolemic compounds
App 20070078098 - DeVita; Robert J. ;   et al.
2007-04-05
Naphthyl compounds promote release of growth hormone
Grant 6,121,325 - Chen , et al. September 19, 2
2000-09-19
Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
Grant 5,721,250 - Morriello , et al. February 24, 1
1998-02-24
Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates
Grant 5,622,973 - Morriello , et al. April 22, 1
1997-04-22
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
Grant 5,494,919 - Morriello , et al. February 27, 1
1996-02-27
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
Grant 5,492,916 - Morriello , et al. February 20, 1
1996-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed